Edition:
United States

Qiagen NV (QIA.DE)

QIA.DE on Xetra

30.37EUR
5:29am EST
Change (% chg)

€0.23 (+0.76%)
Prev Close
€30.14
Open
€30.38
Day's High
€30.45
Day's Low
€30.13
Volume
75,373
Avg. Vol
572,824
52-wk High
€34.05
52-wk Low
€25.22

Latest Key Developments (Source: Significant Developments)

Blocktrade - Qiagen Bookrunner Says Deal Upsized To $500 Mln On Convertible Notes
Tuesday, 6 Nov 2018 08:06am EST 

Nov 6 (Reuters) - Qiagen's Bookrunner::BLOCKTRADE - QIAGEN: BOOKRUNNER SAYS DEAL UPSIZED TO $500M; BOOKS TO CLOSE AT 13.30 UK.  Full Article

Qiagen Convertible Notes Bookrunner Says Orders Below 1 Pct Coupon & 27.5 Pct Premium Risk Missing
Tuesday, 6 Nov 2018 06:21am EST 

Nov 6 (Reuters) - Qiagen's Bookrunner Says::BLOCKTRADE - QIAGEN: BOOKRUNNER SAYS ORDERS BELOW 1.00 PERCENT COUPON AND 27.5 PERCENT PREMIUM RISK MISSING; BOOKS CLOSE AT 12:30PM UKT.  Full Article

Qiagen Bookrunner Says Books Are Covered On Convertible Notes
Tuesday, 6 Nov 2018 04:45am EST 

Nov 6 (Reuters) - Qiagen NV's Bookrunner::BLOCKTRADE - QIAGEN: BOOKRUNNER SAYS BOOKS ARE COVERED, FURTHER GUIDANCE TO FOLLOW.  Full Article

Qiagen Announces Convertible Notes Offer
Tuesday, 6 Nov 2018 01:53am EST 

Nov 6 (Reuters) - Qiagen NV ::SAYS LAUNCHES NON-US OFFERING OF CASH SETTLED CONVERTIBLE NOTES COMBINED WITH CONVERTIBLE NOTE HEDGE AND WARRANT TRANSACTIONS.INTENDS TO PLACE NOTES IN AN AGGREGATE VOLUME OF $400 MILLION.NUMBER OF ORDINARY SHARES OF QIAGEN UNDERLYING NOTES WILL BE UP TO 8.5 MILLION, REPRESENTING APPROXIMATELY 3.8% OF CURRENT OUTSTANDING SHARES.INTENDS TO USE PROCEEDS FROM ISSUANCE OF NOTES FOR GENERAL CORPORATE PURPOSES.NOTES WILL HAVE A MATURITY OF 6 YEARS, WILL BE ISSUED AND REDEEMED AT 100% OF THEIR PRINCIPAL AMOUNT, PAY A COUPON BETWEEN 0.75% - 1.25% P. A..INITIAL CONVERSION PRICE WILL BE SET AT A CONVERSION PREMIUM OF 27.5%.  Full Article

Diasorin Launches New Liaison Quantiferon-TB Gold Plus In Partnership With Qiagen
Monday, 17 Sep 2018 01:27am EDT 

Sept 17 (Reuters) - Diasorin Spa ::LAUNCHES NEW LIAISON QUANTIFERON-TB GOLD PLUS ASSAY AS AN AID FOR LATENT TUBERCULOSIS DETECTION IN PARTNERSHIP WITH QIAGEN.SAYS TEST WAS DEVELOPED IN A PARTNERSHIP BETWEEN DIASORIN AND QIAGEN.SAYS TEST WILL BE LAUNCHED IN U.S. BY 2019 AND IN CHINA BY 2020.  Full Article

Qiagen to conduct an up to $200 mln share repurchase program
Wednesday, 31 Jan 2018 04:04pm EST 

Jan 31 (Reuters) - Qiagen Nv ::DGAP-ADHOC: QIAGEN N.V.: QIAGEN TO CONDUCT AN UP TO US$200 MILLION SHARE REPURCHASE PROGRAM.‍REPURCHASE PROGRAM IS SCHEDULED TO BEGIN AT EARLIEST ON FEBRUARY 6, 2018, AND TO BE COMPLETED ON DECEMBER 21, 2018, AT LATEST​.  Full Article

Qiagen to exceed $140 mln of NGS-related sales In 2018
Monday, 8 Jan 2018 02:00am EST 

Jan 8 (Reuters) - Qiagen Nv ::SAYS ‍GOAL SET TO EXCEED $140 MILLION OF NGS-RELATED SALES IN 2018, UP FROM OVER $115 MILLION IN 2017​.  Full Article

Qiagen, DiaSorin partner in automated tuberculosis detection
Monday, 8 Jan 2018 02:00am EST 

Jan 8 (Reuters) - Qiagen Nv ::SAYS ‍QIAGEN AND DIASORIN PARTNER TO OFFER FULLY AUTOMATED TUBERCULOSIS DETECTION WITH QUANTIFERON-TB GOLD PLUS AVAILABLE ON LIAISON ANALYZER SYSTEMS​.SAYS ‍DIASORIN TO ADD NOVEL CONTENT TO ALREADY BROAD LIAISON MENU, OVER 7,000 SYSTEMS INSTALLED​.SAYS ‍ANNOUNCES MILESTONE OF OVER 40 MILLION QUANTIFERON-TB TESTS SINCE LAUNCH​.  Full Article

Diasorin And Qiagen Partner To Offer Fully Automated Solution For Diagnosis Of Tuberculosis
Monday, 8 Jan 2018 01:56am EST 

Jan 8 (Reuters) - DIASORIN SPA ::ANNOUNCES PARTNERSHIP WITH QIAGEN TO OFFER FULLY AUTOMATED SOLUTION FOR DIAGNOSIS OF TUBERCULOSIS.UNDER AGREEMENT, PARTIES ARE DEVELOPING FULLY AUTOMATED VERSION OF QUANTIFERON TEST READ-OUT COMPONENTS.  Full Article

‍Qiagen says it ‍will Take Extraordinary After-Tax Charge On Net Income Of About $110-120 mln In Q4 2017 Due To US Tax Reform
Friday, 22 Dec 2017 04:08pm EST 

Dec 22 (Reuters) - Qiagen Nv ::‍QIAGEN TO TAKE IMPAIRMENT ON DEFERRED TAX ASSETS, INFORMS ON EXPECTED IMPACTS OF NEW U.S. TAX LAW AND OTHER CHANGES IN GLOBAL TAX ENVIRONMENT​.DUE TO US TAX REFORM ‍WILL TAKE EXTRAORDINARY AFTER-TAX CHARGE ON NET INCOME OF ABOUT $110-120 MILLION IN Q4 OF 2017​.WILL ALSO TAKE ‍AN ADDITIONAL EXTRAORDINARY AFTER-TAX CHARGE IN 2018 OF APPROXIMATELY $7 MILLION (OR ABOUT $0.03 PER SHARE)​.‍AS A RESULT, A NEW AFTER-TAX CHARGE OF APPROXIMATELY $10 MILLION IS PLANNED TO BE TAKEN IN Q4 OF 2017​.SAYS ‍DOES NOT EXPECT ANY ADDITIONAL MATERIAL NON-M&A RELATED RESTRUCTURING CHARGES IN 2018​.‍DO NOT AFFECT QIAGEN'S ADJUSTED EPS FORECAST FOR Q4 AND FULL-YEAR 2018.CURRENTLY EXPECTS A PRELIMINARY ADJUSTED TAX RATE FOR FULL-YEAR 2018 OF APPROXIMATELY 20-21%.‍EXTRAORDINARY COSTS WILL BE EXCLUDED FROM ADJUSTED RESULTS​.  Full Article